Spyre Therapeutics, Inc.
SYRE · XNASCIK 1636282fmd_0FA2NSSQYK2ZDY8GV9FJTWMSJVManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2014 to Sep 30, 2026, 48 periods
AI-written
A model wrote this from the company's own SEC filings and our standardized facts. It is not reported fact, not an analyst's estimate, not a rating and not investment advice. Every claim shows what it rests on.
Loading